Sign up USA
Proactive Investors - Run By Investors For Investors

Xoma Corp investors cheering after positive pre-clinical data

The antibody PTH1R is a potential first-in-class therapeutic agent for the treatment of hyperparathyroidism (HPT)
Xoma Corp investors cheering after positive pre-clinical data
PTH1R is a potential therapeutic agent for treating hyperparathyroidism (HPT) and humoral hypercalcemia of malignancy (HHM)

Xoma Corp (NASDAQ:XOMA) shares surged over 18% to $7.68 as it posted positive data from pre-clinical studies on an antibody.

The antibody PTH1R is a potential first-in-class therapeutic agent for the treatment of hyperparathyroidism (HPT) and humoral hypercalcemia of malignancy (HHM).

"Consistent with our new strategy, we are seeking partners with a deep commitment to and an expertise in drug development who are interested in licensing this first-in-class antibody and taking it through the clinical development process,” said chief executive of Xoma Jim Neal.

"While hyperparathyroidism is a classic endocrine disorder, HHM spans both endocrine and oncology specialties," added Professor John Wysolmerski, of the Yale School of Medicine.

"HHM is a life-threatening complication of many advanced cancers and is caused by tumor secretion of the PTH1R ligand, PTH-related peptide, which causes high calcium.

"Since current treatments often fall short of correcting hypercalcemia and many cancer patients die from such high calcium and associated metabolic complications, PTH1R antibodies could prove beneficial for the treatment of this devastating condition



Register here to be notified of future PROAC Company articles
View full PROAC profile View Profile

Proactiveinvestors Timeline

Related Articles

Digital marketing
March 28 2017
Michael Karg, Ebiquity’s CEO, said:“We have already made good progress with our growth acceleration plan, which will replicate our service offering across key territories, further strengthening our ability to service global clients.”
E-mail
October 18 2016
Geographical expansion, product innovation and strategic partnerships continue to be well executed, said house broker finnCap
social-media.jpg
February 20 2017
One particular development of note is Cello Pulsar, a social media analytics tool that has, according to the experts, the potential to be a real winner.
Copyright © Proactiveinvestors.com, 2017. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use